In immune competent mice bearing HCC, we depleted either CD8+ T cells by anti-CD8 or NK cells by anti-NK neutralizing antibodies 1 day before FM treatment (Fig. 5a). This evidence concerns the gene CD8A and hepatocellular carcinoma.